Its conclusion? "For the common conditions studied, a majority of panels proposed changes to disease definitions that increased the number of individuals considered to have the disease, none reported rigorous assessment of potential harms of that widening, and most had a majority of members disclosing financial ties to pharmaceutical companies." Note that "... these findings do not establish a causal link between industry ties and proposals to change disease definitions"
No comments:
Post a Comment